Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

Ditte Bjerre; Laura Ferrero; Majbritt Madsen; Peter R Hansen; Henrik B Rasmussen; INDICES Consortium

doi:10.1097/FPC.0000000000000114

Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

Ditte Bjerre, Laura Ferrero, Majbritt Madsen, Peter R Hansen, Henrik B Rasmussen, INDICES Consortium

Department of Clinical Medicine

2 Citations (Scopus)

Original language	English
Journal	Pharmacogenetics and Genomics
Volume	25
Issue number	3
Pages (from-to)	147
Number of pages	1
ISSN	1744-6872
DOIs	https://doi.org/10.1097/FPC.0000000000000114
Publication status	Published - 13 Mar 2015

Keywords

Carboxylic Ester Hydrolases
Coronary Disease
Cytochrome P-450 CYP2C19
Female
Humans
Male
Platelet Aggregation Inhibitors
Ticlopidine

Access to Document

10.1097/FPC.0000000000000114

Cite this

Bjerre, D., Ferrero, L., Madsen, M., Hansen, P. R., Rasmussen, H. B., & INDICES Consortium (2015). Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenetics and Genomics, 25(3), 147. https://doi.org/10.1097/FPC.0000000000000114

Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. / Bjerre, Ditte; Ferrero, Laura; Madsen, Majbritt et al.
In: Pharmacogenetics and Genomics, Vol. 25, No. 3, 13.03.2015, p. 147.

Research output: Contribution to journal › Comment/debate › Research

Bjerre, D, Ferrero, L, Madsen, M, Hansen, PR , Rasmussen, HB & INDICES Consortium 2015, 'Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease', Pharmacogenetics and Genomics, vol. 25, no. 3, pp. 147. https://doi.org/10.1097/FPC.0000000000000114

@article{bf1e6be724354972ba025497faca4168,

title = "Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease",

keywords = "Carboxylic Ester Hydrolases, Coronary Disease, Cytochrome P-450 CYP2C19, Female, Humans, Male, Platelet Aggregation Inhibitors, Ticlopidine",

author = "Ditte Bjerre and Laura Ferrero and Majbritt Madsen and Hansen, {Peter R} and Rasmussen, {Henrik B} and {INDICES Consortium}",

year = "2015",

month = mar,

day = "13",

doi = "10.1097/FPC.0000000000000114",

language = "English",

volume = "25",

pages = "147",

journal = "Pharmacogenetics and Genomics",

issn = "1744-6872",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Comment on Xie et al.

T2 - The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

AU - Bjerre, Ditte

AU - Ferrero, Laura

AU - Madsen, Majbritt

AU - Hansen, Peter R

AU - Rasmussen, Henrik B

AU - INDICES Consortium

PY - 2015/3/13

Y1 - 2015/3/13

KW - Carboxylic Ester Hydrolases

KW - Coronary Disease

KW - Cytochrome P-450 CYP2C19

KW - Female

KW - Humans

KW - Male

KW - Platelet Aggregation Inhibitors

KW - Ticlopidine

U2 - 10.1097/FPC.0000000000000114

DO - 10.1097/FPC.0000000000000114

M3 - Comment/debate

C2 - 25647335

SN - 1744-6872

VL - 25

SP - 147

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

IS - 3

ER -